The first Cochrane review on this subject (Yelland 2004B) was executed to target solely on prolotherapy injections, adhering to an earlier Cochrane critique of all injection therapies for low‐back pain (Nelemans 2003) during which the sole cure that showed important, sustained reductions in pain and disability at six months https://isconolidineanopiate32086.weblogco.com/26868073/the-best-side-of-use-proleviate-for-back-pain